B · Normal
On October 30, AbbVie expected full-year adjusted earnings per share of 13.95 to 13.99 US dollars, compared with the previous forecast of 13.76 to 13.96 US dollars.
Related telegraphs
[Wells Fargo lowered the target price of many U.S. technology companies, with Sa
10-30 20:01
On October 30, US broker PIPER SANDLER was authorized to repurchase shares of up
10-30 19:59
On October 30, Haina International lowered Intel’s target price from US$105 to U
10-30 19:54
On October 30, Ruijie Financial lowered the target price of Amazon from US$300 t
10-30 19:54
[AbbVie's third quarter revenue was US$17.4 billion, adjusted earnings per share
10-30 19:50
[Goldman Sachs maintains Apple's "buy" rating and raises its 12-month target pri
10-30 19:49
Comments